Re-mark
Duchenne Muscular Dystrophy Therapy Market Analysis by DelveInsight Currently, Sarepta Therapeutics is leading the Duchenne Muscular Dystrophy Therapeutics market with a strong, extensive pipeline and three approved products. Another key player, PTC Therapeutics, has two approved products. To further strengthen the therapeutics pipeline, some of the prominent companies such as Daiichi Sankyo, Pfizer, Solid Biosciences, Reveragen Biopharma, Santhera Pharmaceuticals, Italfarmaco, Taiho Pharmaceutical, FibroGen, Antisense Therapeutics, Capricor Therapeutics, and several others are investigating their therapeutics candidates to improve the treatment scenario and offer potential solutions to the affected patients.
You may like
Hay una escena que el artículo de El Heraldo de Aguascalientes dibuja sin querer: la de un profesionista sentado frente…
🌊 **Happy World Oceans Day!** 🌊On this special day, **WPE Technologies** celebrates the oceans that sustain life on…
#WorldOceansDay, #WPETechnologies, #CleanWater , #sustainability, #WaterTreatment, #waterpurificationsystems, #groundwaterremediation
Esophageal Cancer Surgery in Ahmedabad | Dr. Dhaval Patel
EsophagealCancer, CancerSurgery, #cancertreatment, SurgicalOncology, CancerCare , AhmedabadDoctors, CancerSpecialist